Reading Time: 5 minutes

Rudy Segna, MD is the Associate Director Division of Gynecologic Oncology, Department of Obstetrics and Gynecology & Reproductive Science at Mount Sinai Medical Center in New York City. He has served as the Director of Gynecologic Oncology and the Colposcopy Service at the Naval Medical Center in Virginia and has published multiple articles and chapters in medical journals and textbooks. He is the winner of the 2009 and 2008 Patients Choice Awards.

Reading Time: 2 minutes

A 2012 study in the international Journal of Functional Foods in Health and Disease finds that glycophospholipids significantly reduce intractable fatigue in long-term patients who are positive on the western blot test for Borrelia burgdorferi infection, known as Lyme Disease.1 The western blot is the gold standard test for this infection, which is the most common vector-borne illness in North America.

Reading Time: 4 minutes

It isn’t every newsletter issue that FOCUS has the privilege of featuring a scientist whose theory of a fundamental biological phenomenon is accepted throughout the biological and medical sciences as the standard textbook model. Such is the case with S. J. Singer’s and Garth Nicolson’s landmark theory of the Fluid Mosaic Model of cell membranes. This model, proposed in 1972 and published in the prestigious journal SCIENCE, has been called a “unified theory” of the cell membrane. This model has been tested and retested for many decades, and it is now believed to accurately predict the structure and behaviour of all cellular membranes. Over the intervening years this theory has been confirmed by many sophisticated physical and chemical techniques, including one known as freeze-fracture electron microscopy.

Reading Time: 4 minutes

In the mid-1960s I had the honour of working with Professor S. J. Singer on the Fluid Mosaic Model of Biological Membranes for my doctoral thesis. At the time the cell membrane was thought to be a rather static three-layer structure with lipids sandwiched in between protein inner and outer layers. However, we knew that this static 3-layer structure did not fit with the wide range of physical and chemical information that had recently become available on membrane structure.

Reading Time: 4 minutes

By Dr Stephen Levine PhD.

This issue of FOCUS has special meaning for me. It reaches back in time to the incredible excitement generated in the early 1970’s by the stunning discoveries of Singer and Nicolson. These two scientists deciphered the actual biochemical structure of the cellular membrane. They called it the Lipid Bi-Layer Fluid Mosaic Model. I was a graduate student in genetics at UC Berkeley. Their model was talked about in laboratories, over lunch tables, and in classrooms. It was a truly exciting time.

Reading Time: 11 minutes

By Michael E. Ash BSc DO ND and Garth L. Nicolson, PhD

On the front line of primary care the two most common complaints are fatigue and gastrointestinal problems. Fatigue is the most common; up to 45% of consultations mention fatigue as the major complaint.[1],[2] If unresolved, it can progress to the point that it causes disability comparable to that found in chronic medical patients.[3],[4]

Reading Time: 13 minutes

Michael E. Ash BSc DO ND, Robert Settenari M.S and Prof. Garth L. Nicolson Ph.D explain the relationship between energy deficit, mitochondrial membrane quality, the immune system, inflammation and how to recover from persistent fatigue using validated natural medicine.

Glycophospholipids and their Effect on Fatigue

Wednesday, 07 March 2012 by | Comments: 21
Reading Time: 12 minutes

Michael Ash interviewed colleague Dr Rita Ellithorpe MD for CAM on the clinical application of a patent pending form of phospholipids known as glycophospholipids and commercially sold as NT Factor and referred to as Lipid Replacement Therapy® (LRT®).

Unusually for many food supplements, glycophospholipids have been the primary ingredient in a number of research papers, some of which has had Dr Ellithorpe as a primary contributor. Her colleagues in this work have included Prof Garth Nicolson and Dr Settenari. References relating to some of these studies may be found at the end of the interview. LRT® is scientifically validated in 9 preclinical and clinical trials over the past 15 years, with millions of doses safely taken by consumers.  More than 25 articles in scientific and medical journals have been published on its benefits.